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19th CardioVascular Summit: TCTAP 2014He was chronic ill-looking appearance with cyanosis. He showed mild growth
restriction with 140 centimeters height (3-10 percentile) and 23 kilograms weight
(3-10p). Blood pressure was 104/50 mmHg; heart rate was 100 pulse/min; respiratory
rate was 24 breath/min and body temperature was 36.8 centigrade. Pulse oxymetry
showed decreased saturation, 80 % in room air. Physical examination showed regular
heart beat, grade 2 to 3 continous murmur on left upper sternal border and grade 2
pansystolic murmur on apex. Chest x-ray showed no cardiomegaly (cardio-thoracic
ratio: 0.50) and electrocardigraphy showed normal sinus rhythm, biatrial enlargement
but there was no abnormal rhythm and no intracardiac conduction delay.
Relevant test results prior to catheterization:
Echocardiography revealed his complex congenital heart disease: pumlnonary atresia
with ECD, hypoplastic pulmonary arteries (PAs) and MAPCAs. He has a functional
single ventricle with rudimentary left ventricle (LV) and aorta from right ventricle (RV).
There was a common atrium and grade 2 common atrioventricular valve regurgitation
with 87mmHg pressure gradients. There were associated venous anomalies; bilateral
superior vena cava (SVC) -left sided SVC drains to left sided atrium, four pulmonary
veins consists of one common pulmonary vein which drains to left sided atrium.
Myocardial function was mildly decreased with 50% of ejection fraction.
Relevant catheterization ﬁndings:
The ﬁrst angiogram showed hypoplastic native PAs (right PA, 2.5mm; left PA,
2.8mm) and six MAPCAs. MAPCA 1 was emerging from the right subclavian artery
and was connected to the right upper pulmonary lobe. MAPCAs 2 and 3 were
emerging from the descending aorta and was connected to the right upper lobe and
right lower lobe. MAPCA 4 was emerging from aortic arch and was connected to left
upper lobe. MAPCAs 5 and 6 were emerging from descending aorta to left lower lobe
superior segment and posterior segement. He underwent three angiographies for
increasing pulmonary artery ﬂow.
[Interventional Management]
Procedural step:
The second angiographywas performed four days after theﬁrst angiography. Retrograde
balloon angioplasty and stent insertion on RVOT was done successfully and balloon
angioplasty of MAPCAs 4, 5 were also done. After one year later, he received two
angiographies (Aug, 2011 with 10 yr-old ages). Ballon angioplasty was done on stent
insertion site of RVOT, LPA and RPA at the third angiography and balloon angioplasty
was done on RVOT and RPA junctional stenosis at the fourth angiography. Two
MAPCAs occlusion angiography was performed. Fifth angiography perfomed on Aug.
2012 showed intact pulmonary arteryﬂow.Main branch ofMAPCAs 2, 3were occluded
with coil and vascular plug. Branches of MAPCAs 2, 3 were occluded on Aug, 2013.
Case Summary:
Reconstruction of Atretic RVOT by transcatheter technique maybe feasible in selec-
tive cases. This technique along with occlusion of feading MAPCAs from aorta to
native PAs may promote siginiﬁcant growth of native pulmonary arterial trees. We
report a case of transcatheter rehabilitation of pulmonary arteries in PA VAS with
MAPCAs, in which case surgical treatment had been hesitated by surgeons.S146 JACC Vol 63/12/Suppl S j ATCTAP C-127
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[Clinical Information]
Patient initials or identiﬁer number:
S.O
Relevant clinical history and physical exam:
A patent ductus arteriosus (PDA) was detected in a 6 month-old female with Down
syndrome. She was referred to our hospital after screening echocardiography at 10
days after birth. Her height was 61.5 cm and body weight was 6.1 kg. A grade 3/6
continuous murmur over the upper left sternal border, and bounding pulses.
Relevant test results prior to catheterization:
A chest X-ray showed marked cardiomegaly and increased pulmonary vascularity.
Her electrocardiogram documented mild left ventricular hypertrophy. Doppler echo-
cardiograms showed a continuous ﬂow from descending aorta to the main pulmonary
artery, while the left atrium and the left ventricle were dilated (left ventricular end
diastolic dimension was 130% of normal), and left ventricular ejection fraction was
86%. There was mitral regurgitation of mild degree, while tricuspid regurgitation
velocity was 3.9 m/sec which suggested mild pulmonary hypertension.
Relevant catheterization ﬁndings:
The PDA was Krichenko type A with the narrowest diameter of 3.3 mm. The isthmus
of aortic arch was slightly hypoplastic with a lumen diameter of 5.5mm, though there
was no pressure gradient. Cardiac catheterization demonstrated pulmonary to systemic
ﬂow ratio of 3.1, complicated by mild pulmonary hypertension (mean pulmonary
arterial pressure of 32 mmHg).
[Interventional Management]
Procedural step:
First, we closed the PDA using an Amplatzer Duct Occluder (ADO) (9-PDA-005) with
the standard technique. However, the entire device (including the aortic retention skirt)
was deployed within the body of the duct (so called "bump" positioning). Further
device manipulation to deploy without bumping resulted in its dislodgement into the
pulmonary artery without resistance. Consequently, we judged that the device was
undersized and tried to size up to ADO (9-PDA-006). Although the post-occlusion
aortography with a pigtail catheter in the proximal transverse aortic arch showed that
the aortic retention skirt protruded into the aortic lumen, there was no pull back pressure
gradient. The ADO was released from its delivery system and the degree of protrusion
of the retention skirt was slightly turned worse. Although there was no turbulence by
Doppler echocardiography shortly after deployment, a peak velocity of 3.2 m/s with a
mild coarcrtation ﬂow pattern was detected in the next day, without a signiﬁcant dif-
ference of blood pressure by cuff between the upper and the lower extremity. Cardiac
catheterization after 3 months shows a pressure gradient of 30mmHg across the site of
the narrowing. At this moment, the patient has been carefully observed on further
deterioration of the pressure difference and on left ventricular hypertrophy.
Case Summary:
A 6-month-old girl with a patent ductus arteriosus (PDA) complicated by Down syn-
drome. The PDA was Krichenko type A with the narrowest diameter of 3.3 mm. The
isthmus of aortic arch was slightly hypoplastic with a lumen diameter of 5.5mm, though
there was no pressure gradient. Cardiac catheterization demonstrated pulmonary to
systemic ﬂow ratio of 3.1, complicated by mild pulmonary hypertension (mean pul-
monary arterial pressure of 32 mmHg). First, we closed the PDA using an ADO
(9-PDA-005) with the standard technique. However, the entire device (including the
aortic retention skirt) was deployed within the body of the duct (so called "bump"
positioning). Further device manipulation to deploy without bumping resulted in its
dislodgement into the pulmonary artery without resistance. Consequently, we judged
that the device was undersized and tried to size up to ADO (9-PDA-006). Although the
post-occlusion aortography with a pigtail catheter in the proximal transverse aortic arch
showed that the aortic retention skirt protruded into the aortic lumen, there was no pull
back pressure gradient. The ADO was released from its delivery system and the degree
of protrusion of the retention skirt was slightly turned worse. Although there was no
turbulence by Doppler echocardiography shortly after deployment, a peak velocity of
3.2 m/s with a mild coarcrtation ﬂow pattern was detected in the next day, without a
signiﬁcant difference of blood pressure by cuff between the upper and the lower ex-
tremity. Cardiac catheterization after 3 months shows a pressure gradient of 30mmHg
across the site of the narrowing. At this moment, the patient has been carefully observed
on further deterioration of the pressure difference and on left ventricular hypertrophy.pril 22–25, 2014 j TCTAP Abstracts/CASE/Congenital Heart Disease
